title: Prostacyclin receptor deletion aggravates hippocampal neuronal loss after bilateral common carotid artery occlusion in mouse.
abstract: Transient global cerebral ischemia causes delayed neuronal death in the hippocampal CA1 region. It also induces an increase in cyclooxygenase 2 (COX-2), which generates several metabolites of arachidonic acid, known as prostanoids, including prostacyclin (PGI(2)). To determine the role of the PGI(2) receptor (IP) in post-ischemic delayed cell death, wild-type and IP knockout (IP(-/-)) C57Bl/6 mice were subjected to 12-min bilateral common carotid artery occlusion or sham surgery, followed by 7 days of reperfusion. In the sham-operated mice, no statistical difference in CA1 hippocampal neuronal density was observed between the wild-type (2836+/-18/mm(2)) and IP(-/-) (2793+/-43/mm(2)) mice. Interestingly, in animals subjected to ischemia, surviving neuronal density in wild-type mice decreased to 50.5+/-7.9% and that of IP(-/-) mice decreased to 23.0+/-4.5% of their respective sham-operated controls (P<0.05). The results establish a role for the IP receptor in protecting pyramidal hippocampal neurons after this global ischemic model and suggest that IP receptor agonists could be developed to prevent delayed pyramidal neuronal cell death.
authors.affiliation: Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, MD 21205, USA.
authors.forename: G
authors.initials: G
authors.lastname: Wei
authors.forename: K K
authors.initials: KK
authors.lastname: Kibler
authors.forename: R C
authors.initials: RC
authors.lastname: Koehler
authors.forename: T
authors.initials: T
authors.lastname: Maruyama
authors.forename: S
authors.initials: S
authors.lastname: Narumiya
authors.forename: S
authors.initials: S
authors.lastname: Doré
mesh_terms: D000818:Animals; D001794:Blood Pressure / Q000235:genetics; D001831:Body Temperature / Q000235:genetics; D002545:Brain Ischemia / Q000209:etiology / Q000235:genetics / Q000473:pathology; D002340:Carotid Artery Diseases / Q000150:complications / Q000235:genetics* / Q000473:pathology*; D016923:Cell Death / Q000502:physiology; D002560:Cerebrovascular Circulation / Q000235:genetics / Q000502:physiology; D004195:Disease Models, Animal; D006624:Hippocampus / Q000473:pathology*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D017966:Pyramidal Cells / Q000473:pathology* / Q000503:physiopathology*; D044006:Receptors, Epoprostenol / Q000172:deficiency*; D015424:Reperfusion
chemical_list: D044006:Receptors, Epoprostenol
references.citation: Clin Exp Rheumatol. 1991 May-Jun;9(3):271-3
references.pmid: 1879086
references.citation: Eur J Neurosci. 1999 Sep;11(9):3115-24
references.pmid: 10510175
references.citation: Ann Neurol. 2003 Aug;54(2):155-62
references.pmid: 12891667
references.citation: Cochrane Database Syst Rev. 2004;(3):CD000177
references.pmid: 15266425
references.citation: Ann Neurol. 1998 Jun;43(6):738-47
references.pmid: 9629843
references.citation: Physiol Rev. 1999 Oct;79(4):1193-226
references.pmid: 10508233
references.citation: Am J Physiol. 1997 Mar;272(3 Pt 2):H1323-32
references.pmid: 9087608
references.citation: Stroke. 1983 Mar-Apr;14(2):197-202
references.pmid: 6340253
references.citation: Vasa. 1998 Feb;27(1):15-9
references.pmid: 9540427
references.citation: Brain Res. 2002 Jan 25;925(2):176-82
references.pmid: 11792366
references.citation: Neuroreport. 1998 May 11;9(7):1317-9
references.pmid: 9631421
references.citation: Prostaglandins. 1978 Sep;16(3):373-88
references.pmid: 364545
references.citation: Pharmacol Ther. 1991;49(3):153-79
references.pmid: 1905023
references.citation: Eur J Pharmacol. 2002 Aug 2;449(1-2):127-133
references.pmid: 12163116
references.citation: Toxicol Sci. 2006 Jan;89(1):265-70
references.pmid: 16237196
references.citation: Stroke. 1983 Mar-Apr;14(2):203-9
references.pmid: 6340254
references.citation: Circulation. 2005 Feb 15;111(6):796-803
references.pmid: 15699263
references.citation: Neurosci Lett. 2002 Apr 5;322(2):91-4
references.pmid: 11958851
references.citation: Stroke. 1997 Sep;28(9):1797-804
references.pmid: 9303028
references.citation: Prostaglandins. 1990 Sep;40(3):241-8
references.pmid: 2123354
references.citation: Biochem Biophys Res Commun. 1999 Nov 19;265(2):301-4
references.pmid: 10558861
references.citation: Am J Physiol Regul Integr Comp Physiol. 2001 Nov;281(5):R1343-60
references.pmid: 11641101
references.citation: Annu Rev Pharmacol Toxicol. 2001;41:661-90
references.pmid: 11264472
references.citation: Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10954-9
references.pmid: 9724811
references.citation: Acta Anaesthesiol Scand. 2004 Nov;48(10):1316-21
references.pmid: 15504195
references.citation: Stroke. 2001 Jul;32(7):1598-606
references.pmid: 11441207
references.citation: J Cereb Blood Flow Metab. 2004 Jan;24(1):62-6
references.pmid: 14688617
references.citation: Physiol Rev. 1998 Jan;78(1):53-97
references.pmid: 9457169
references.citation: J Biol Chem. 1994 Apr 22;269(16):12173-8
references.pmid: 7512962
references.citation: Brain Res. 1997 Sep 26;769(2):321-8
references.pmid: 9374201
references.citation: Cell. 2004 Sep 17;118(6):665-6
references.pmid: 15369664
references.citation: Mol Pharmacol. 1994 Aug;46(2):213-20
references.pmid: 8078484
references.citation: Neurology. 1982 Sep;32(9):970-4
references.pmid: 7050766
references.citation: Prog Neurobiol. 1998 Oct;56(2):149-71
references.pmid: 9760699
references.citation: Nature. 1997 Aug 14;388(6643):678-82
references.pmid: 9262402
references.citation: Br J Pharmacol. 1982 May;76(1):3-31
references.pmid: 7044460
references.citation: Neurology. 2001;57(5 Suppl 2):S5-7
references.pmid: 11552047
references.citation: Masui. 1987 Nov;36(11):1790-5
references.pmid: 3328793
references.citation: Neuroscience. 2004;128(1):65-71
references.pmid: 15450354
references.citation: J Neurosci. 1986 Oct;6(10):2950-67
references.pmid: 3760943
references.citation: J Cereb Blood Flow Metab. 2004 Feb;24(2):151-8
references.pmid: 14747741
references.citation: Acta Neurochir Suppl. 2003;86:97-100
references.pmid: 14753414
references.citation: J Pharmacol Sci. 2003 Apr;91(4):305-12
references.pmid: 12719659
references.citation: Am J Physiol. 1999 Jul;277(1):H299-307
references.pmid: 10409209
references.citation: J Pharmacol Exp Ther. 1998 Aug;286(2):1094-102
references.pmid: 9694973
references.citation: Pharmacol Biochem Behav. 1995 Nov;52(3):555-9
references.pmid: 8545473
references.citation: J Trauma. 1994 Sep;37(3):347-57
references.pmid: 8083892
references.citation: Kardiol Pol. 2003 Sep;59(9):197-204
references.pmid: 14618196
references.citation: Acta Neuropathol. 1999 Jul;98(1):9-14
references.pmid: 10412795
references.citation: J Neurosci Methods. 1999 Apr 1;88(1):103-9
references.pmid: 10379584
references.citation: J Neurosurg. 2002 Jul;97(1):104-11
references.pmid: 12134899
references.citation: J Cereb Blood Flow Metab. 1998 May;18(5):570-9
references.pmid: 9591849
references.citation: J Clin Invest. 2001 Jul;108(1):25-30
references.pmid: 11435452
references.citation: Brain Res. 2005 Dec 20;1066(1-2):71-7
references.pmid: 16360658
references.citation: Am Heart J. 1999 Jan;137(1):39-48
references.pmid: 9878935
references.citation: Tohoku J Exp Med. 2005 Sep;207(1):51-8
references.pmid: 16082155
references.citation: J Neurosurg. 1999 Nov;91(5):835-42
references.pmid: 10541242
references.citation: Stroke. 2004 Feb;35(2):520-6
references.pmid: 14726553
references.citation: J Neurosurg. 1997 Jun;86(6):1007-11
references.pmid: 9171180
references.citation: Cerebrovasc Dis. 1998 Nov-Dec;8(6):310-7
references.pmid: 9774747
references.citation: J Clin Invest. 2004 Sep;114(6):784-94
references.pmid: 15372102
references.citation: Circulation. 1994 Oct;90(4):1643-7
references.pmid: 7923647
references.citation: Stroke. 1998 Dec;29(12):2616-21
references.pmid: 9836775
references.citation: Brain Res. 2003 Aug 29;982(2):260-9
references.pmid: 12915260
references.citation: Circulation. 2004 Jun 8;109(22):2786-91
references.pmid: 15159295